Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Postoperative Delirium Prophylaxis in Open Heart Surgery
NCT05801289Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of quetiapine in delirium (2 arms), sponsored by Ain Shams University. Primary endpoint: Delirium Incidence. Status: unknown.
02
Drugs
quetiapine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT05801289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05801289.